Mobocertinib succinate
Modify Date: 2025-08-25 13:53:15
Mobocertinib succinate structure
|
Common Name | Mobocertinib succinate | ||
|---|---|---|---|---|
| CAS Number | 2389149-74-8 | Molecular Weight | 703.78 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C36H45N7O8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Mobocertinib succinateMobocertinib succinate (compound A) is a potent epidermal growth factor receptor (EGFR) inhibitor and an antineoplastic agent, extracted from patent WO2019222093A1, compound A[1][2]. |
| Name | Mobocertinib succinate |
|---|---|
| Synonym | More Synonyms |
| Description | Mobocertinib succinate (compound A) is a potent epidermal growth factor receptor (EGFR) inhibitor and an antineoplastic agent, extracted from patent WO2019222093A1, compound A[1][2]. |
|---|---|
| Related Catalog | |
| References |
[1]. International Nonproprietary Names for Pharmaceutical Substances (INN). |
| Molecular Formula | C36H45N7O8 |
|---|---|
| Molecular Weight | 703.78 |
| MFCD32689632 |